Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 16, Number 6—June 2010


Rhinovirus C and Respiratory Exacerbations in Children with Cystic Fibrosis

Marina B. de AlmeidaComments to Author , Rodrigo M. Zerbinati, Adriana F. Tateno, Cristina M. Oliveira, Renata M. Romão, Joaquim C. Rodrigues, Cláudio S. Pannuti, and Luiz Vicente F. da Silva FilhoComments to Author 
Author affiliations: Hospital das Clínicas da Faculdade de Medicina de Universidade de São Paulo, São Paulo, Brazil (M.B. de Almeida, J.C. Rodrigues, L.V.F. da Silva Filho); Universidade de São Paulo, São Paulo (R.M. Zerbinati, A.F. Tateno, C.M. Oliveira, R.M. Romão, C.S. Pannuti, L.V.F. da Silva Filho)

Main Article

Table 2

Virologic test results and respiratory exacerbation outcome for 103 children with cystic fibrosis, Brazil, 2006–2007*

Virus OR (95% CI) p value
Any respiratory virus 1.063 (0.979–1.154) 0.144
Rhinovirus 1.020 (0.931–1.117) 0.666
Any respiratory virus except rhinoviruses 1.195 (1.043–1.369) 0.010
Rhinovirus A2 or C (excluding samples not sequenced) 1.213 (1.024–1.436) 0.025

*Estimates from binomial, generalized linear models. OR, odds ratio; CI, confidence interval.

Main Article

Top of Page The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO